Proposed Merger of British Biotech and RiboTargets
21 March 2003
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, BELGIUM, CANADA, AUSTRALIA, SOUTH AFRICA OR JAPAN
The boards of British Biotech and RiboTargets are pleased to announce that they have agreed the terms of a Merger of the two companies to create a Merged Group with a pro-forma market capitalisation of £52 million and Net Cash as at 28 February of £43.5 million, with a further £7.9 million receivable from certain RiboTargets shareholders upon completion of the Merger.
View the full press release (PDF file - 660KB)
----ends----
